Global Antibiotic R&D Partnership (GARDP)
Martinette Nel has extensive experience in pharmaceutical research and development, serving as Clinical QA & Portfolio Senior Officer at the Global Antibiotic R&D Partnership (GARDP) since March 2018, and previously as R&D Senior Programmes Assistant at the Drugs for Neglected Diseases initiative (DNDi). Prior roles include Project Support Specialist at Quintiles from November 2012 to September 2017, Pharmacy Technician at Addenbrooke's PGMC from September 2008 to March 2010, and Responsible Pharmacist in various clinics and hospitals within the Western Cape health system from January 2005 to March 2007. Martinette obtained a Bachelor of Pharmacy (B.Pharm.) degree from North-West University between 2000 and 2005.
This person is not in any offices
Global Antibiotic R&D Partnership (GARDP)
The Global Antibiotic Research & Development Partnership (GARDP) is a not-for-profit organization that develops new antibiotic treatments for drug-resistant bacterial infections that pose the greatest threat to human health, and makes them accessible to the people who need them. It puts public health needs at the centre of antibiotic drug development to address both the immediate antimicrobial resistance (AMR) crisis and to ensure people continue to get access to essential antibiotics for generations to come. GARDP works through a global network including Brazil, India, Japan, and South Africa for antibiotic development and access. Its work is made possible by essential funding from donors and collaboration with over 100 R&D and access partners in over 20 countries. GARDP was created by the World Health Organization and the Drugs for Neglected Diseases initiative (DNDi) in 2016 and legally registered as the GARDP Foundation in Geneva, Switzerland in 2018. www.gardp.org